Trials / Completed
CompletedNCT00215254
Quetiapine in Social Anxiety Disorder
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Quetiapine in Social Anxiety Disorder
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 15 (planned)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to examine the effectiveness and tolerability of quetiapine for the treatment of social anxiety disorder (SAD). The hypothesis is that quetiapine will be effective and well-tolerated for patients with social anxiety disorder.
Detailed description
This is an eight week, randomized, double-blind, placebo-controlled trial of quetiapine (100-400 mg/day)in social anxiety disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quetiapine |
Timeline
- Start date
- 2004-03-01
- Completion
- 2006-02-01
- First posted
- 2005-09-22
- Last updated
- 2006-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00215254. Inclusion in this directory is not an endorsement.